# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Chronic granulomatous disease, x-linked

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-16 of 16 results.
Vitamin D3 For CGD Patients With BCGosis/Itis
Status: Recruiting
Last Changed: Oct 22, 2019
First Received: Jun 13, 2019
Disease(s): Vitamin D3, Chronic-granulomatous Disease, BCG
Intervention(s): Vitamin D3, Traditional treatment of CGD and TB
Locations: Children's Hospital of Fudan University, Shanghai, Shanghai, China
Children's Hospital of Fudan University, Shanghai, Shanghai, China
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
Status: Recruiting
Last Changed: Apr 03, 2020
First Received: Sep 12, 2017
Disease(s): Chronic Granulomatous Disease, Inflammatory Bowel Disease
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Immune Disorder HSCT Protocol
Status: Recruiting
Last Changed: Mar 26, 2019
First Received: Apr 01, 2013
Disease(s): Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease, X-linked Agammaglobulinemia, Wiskott-Aldrich Syndrome, Hyper-IgM, DiGeorge Syndrome, Chediak-Higashi Syndrome, Common Variable Immune Deficiency, Immune Dysregulatory Disorders, Hemophagocytic Lymphohistiocytosis, IPEX, Autoimmune Lymphoproliferative Syndrome, X-linked Lymphoproliferative Syndrome
Intervention(s): Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
Locations: Washington University, Saint Louis, Missouri, United States
Methodist Heathcare, San Antonio, Texas, United States
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
Status: Recruiting
Last Changed: Feb 13, 2020
First Received: Apr 09, 2014
Disease(s): HIV, Cancer, Chronic Granulomatous Disease, Dock 8 Deficiency
Locations: Children's Hospital of Orange County, Orange, California, United States
Childrens National Medical Center, Washington, District of Columbia, United States
Moffitt Cancer Center, Tampa, Florida, United States
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
... and 4 other locations.
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
Status: Recruiting
Last Changed: Jan 28, 2020
First Received: May 01, 2018
Disease(s): Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Acquired Neutropenia in Newborn, Acquired Anemia Hemolytic, Acquired Thrombocytopenia, Hemophagocytic Lymphohistiocytoses, Wiskott-Aldrich Syndrome, Chronic Granulomatous Disease, Common Variable Immunodeficiency, X-linked Lymphoproliferative Disease, Severe Combined Immunodeficiency, Hurler Syndrome, Mannosidosis, Adrenoleukodystrophy
Intervention(s): Thiotepa--single daily dose, Thiotepa--escalated dose
Locations: UF Health Shands Children's Hospital, Gainesville, Florida, United States
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Status: Recruiting
Last Changed: Jan 07, 2020
First Received: Jul 27, 2012
Disease(s): SCID, Omenn's Syndrome, Reticular Dysgenesis, Wiskott-Aldrich Syndrome, Bare Lymphocyte Syndrome, Common Variable Immunodeficiency, Chronic Granulomatous Disease, CD40 Ligand Deficiency, Hyper IgM Syndrome, X-linked Lymphoproliferative Disease, Hemophagocytic Lymphohistiocytosis, Griscelli Syndrome, Chediak-Higashi Syndrome, Langerhan's Cell Histiocytosis
Intervention(s): Alemtuzumab 0.3 mg, Cyclophosphamide, Busulfan, Stem Cell Transplantation, Fludarabine phosphate 40 mg, Melphalan, Alemtuzumab 0.2 mg, Busulfan, Fludarabine phosphate 30 mg, MESNA
Locations: Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States